KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Capital Expenditures (2017 - 2025)

Elanco Animal Health's Capital Expenditures history spans 9 years, with the latest figure at $62.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 31.91% year-over-year to $62.0 million; the TTM value through Dec 2025 reached $276.0 million, up 87.76%, while the annual FY2025 figure was $276.0 million, 87.76% up from the prior year.
  • Capital Expenditures for Q4 2025 was $62.0 million at Elanco Animal Health, down from $92.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $99.0 million in Q4 2021 and bottomed at $5.0 million in Q1 2021.
  • The 5-year median for Capital Expenditures is $41.5 million (2023), against an average of $44.6 million.
  • The largest YoY upside for Capital Expenditures was 861.54% in 2021 against a maximum downside of 84.38% in 2021.
  • A 5-year view of Capital Expenditures shows it stood at $99.0 million in 2021, then dropped by 22.22% to $77.0 million in 2022, then crashed by 46.75% to $41.0 million in 2023, then grew by 14.63% to $47.0 million in 2024, then surged by 31.91% to $62.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Capital Expenditures are $62.0 million (Q4 2025), $92.0 million (Q3 2025), and $57.0 million (Q2 2025).